Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

271 ARTÍCULOS , VIENDO DEL 211 AL 225

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217

Kovacech B, Cullen NC, Novak P, Hanes J, Kontsekova E, Katina S, Parrak V, Fresser M, Vanbrabant J, Feldman HH, Winblad B, Stoops E, Vanmechelen E, Zilka N.

Alzheimers Res Ther. 2024 Nov 23;16(1):254. doi: 10.1186/s13195-024-01620-7.

Navigating the Alzheimer's Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics

El Abiad E, Al-Kuwari A, Al-Aani U, Al Jaidah Y, Chaari A.

Cells. 2024 Nov 18;13(22):1901. doi: 10.3390/cells13221901.

Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications

Roveta F, Bonino L, Piella EM, Rainero I, Rubino E.

Int J Mol Sci. 2024 Nov 6;25(22):11941. doi: 10.3390/ijms252211941.

Blood-based microRNAs as the potential biomarkers for Alzheimer's disease: evidence from a systematic review

Fattahi F, Asadi MR, Abed S, Kouchakali G, Kazemi M, Mansoori Derakhshan S, Shekari Khaniani M.

Metab Brain Dis. 2024 Nov 28;40(1):44. doi: 10.1007/s11011-024-01431-7.

Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications

Jamerlan AM, An SSA, Hulme JP.

J Neurol Sci. 2024 Dec 15;467:123325. doi: 10.1016/j.jns.2024.123325. Epub 2024 Nov 22.

Unlocking early detection of Alzheimer's disease: The emerging role of nanomaterial-based optical sensors

Chen CH, Liang HH, Wang CC, Yang YT, Lin YH, Chen YL.

J Food Drug Anal. 2024 Sep 13;32(3):296-324. doi: 10.38212/2224-6614.3520.

Medication Exposure and Risk of Dementia and Alzheimer's Disease

Sharma N, An SSA, Kim SY.

Int J Mol Sci. 2024 Nov 29;25(23):12850. doi: 10.3390/ijms252312850.

Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis

Lombardi G, Pancani S, Manca R, Mitolo M, Baiardi S, Massa F, Coppola L, Franzese M, Nicolai E, Guerini FR, Mancuso R, Agliardi C, Agostini S, Pardini M, Virgili G, Sorbi S, Parchi P, Nacmias B, Venneri A.

Int J Mol Sci. 2024 Nov 30;25(23):12916. doi: 10.3390/ijms252312916.

[Research progress of MCP-1 in the pathogenesis of Alzheimer's disease]

Xu Y, Li Q, Mao S, Yang K, Yang S.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Dec;40(12):1115-1120.

Advances in Alzheimer's Disease Biomarkers

Li K, Gao Y, Liu M, Chen Y.

Curr Alzheimer Res. 2024;21(11):791-803. doi: 10.2174/0115672050366767241223050957.

Understanding the Molecular Impact of Physical Exercise on Alzheimer's Disease

Cantón-Suárez A, Sánchez-Valdeón L, Bello-Corral L, Cuevas MJ, Estébanez B.

Int J Mol Sci. 2024 Dec 18;25(24):13576. doi: 10.3390/ijms252413576.

Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort

Puerta R, Cano A, García-González P, García-Gutiérrez F, Capdevila M, de Rojas I, Olivé C, Blázquez-Folch J, Sotolongo-Grau O, Miguel A, Montrreal L, Martino-Adami P, Khan A, Orellana A, Sung YJ, Frikke-Schmidt R, Marchant N, Lambert JC, Rosende-Roca M, Alegret M, Fernández MV, Marquié M, Valero S, Tárraga L, Cruchaga C, Ramírez A, Boada M, Smets B, Cabrera-Socorro A, Ruiz A.

Int J Mol Sci. 2024 Dec 31;26(1):286. doi: 10.3390/ijms26010286.

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers

Kimura T, Sato H, Kano M, Tatsumi L, Tomita T.

FEBS Open Bio. 2024 Feb;14(2):181-193. doi: 10.1002/2211-5463.13667. Epub 2023 Jul 8.

ADAM10 as a biomarker for Alzheimer's disease: A systematic review

Oliveira Monteiro E Pereira de Almeida MP, Valle Pedroso R, Mantellatto Grigoli M, Vicente Silva T, Manzine PR, Cominetti MR.

Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):1-11. doi: 10.1016/j.neurol.2023.04.002. Epub 2023 Jul 16.

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders

Eratne D, Kang M, Malpas C, Simpson-Yap S, Lewis C, Dang C, Grewal J, Coe A, Dobson H, Keem M, Chiu WH, Kalincik T, Ooi S, Darby D, Brodtmann A, Hansson O, Janelidze S, Blennow K, Zetterberg H, Walker A, Dean O, Berk M, Wannan C, Pantelis C, Loi SM, Walterfang M, Berkovic SF, Santillo AF, Velakoulis D.

Aust N Z J Psychiatry. 2024 Jan;58(1):70-81. doi: 10.1177/00048674231187312. Epub 2023 Jul 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias